Loading…
Mangoceuticals, Inc. is projected to rise to $0.8289 by 2027, a +55% move from its current price of $0.536. MGRX is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/4/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $0.4838 | $0.537 | $0.5962 | +0.20% |
| Aug 6 | $0.4642 | $0.5381 | $0.6238 | +0.39% |
| Aug 7 | $0.4499 | $0.5392 | $0.6461 | +0.59% |
| Aug 8 | $0.4383 | $0.5402 | $0.6658 | +0.78% |
| Aug 9 | $0.4285 | $0.5413 | $0.6838 | +0.98% |
| Aug 10 | $0.4198 | $0.5423 | $0.7006 | +1.18% |
| Aug 11 | $0.4121 | $0.5434 | $0.7165 | +1.38% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.4121 | $0.5434 | $0.7165 | +1.38% |
| Week 2 | $0.3726 | $0.5509 | $0.8145 | +2.77% |
| Week 3 | $0.3459 | $0.5585 | $0.9016 | +4.19% |
| Week 4 | $0.3256 | $0.5661 | $0.9843 | +5.62% |
| Week 5 | $0.3093 | $0.5739 | $1.07 | +7.08% |
| Week 6 | $0.2956 | $0.5818 | $1.15 | +8.55% |
| Week 7 | $0.2838 | $0.5899 | $1.23 | +10.05% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Mangoceuticals, Inc. engages in the development, marketing, and sale of various men’s wellness products and services through a telemedicine platform in the United States. The company offers erectile dysfunction products under the Mango brand; hair loss products under the Grow brand; hormone balance and therapy products under the Mojo brand; and weight loss products under the Slim brand.
It also provides oral testosterone undecanoate to treat low testosterone in men and as a form of testosterone replacement therapy under the Prime brand; and access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations. In addition, the company markets and sells its products online through MangoRX.com. The company was incorporated in 2021 and is headquartered in Dallas, Texas.
Mangoceuticals, Inc. operates as a subsidiary of Cohen Enterprises, Inc.
Mangoceuticals, Inc. trades under the symbol MGRX with a current price of $0.5571 and a market cap of $9.56M. It is ranked 5101. The price outlook is described by a year‑by‑year forecast that shows a long‑term upside path, with average prices advancing across multiple years and a sequence of higher highs implied by the max values.
By 2050, the forecast lists an average price of $5.27 and a max of $12.12, corresponding to an about‑year ROI of 845.5% and a bullish sentiment in the later horizon.
A major floor 62.3% below — a decisive break under it would weaken the trend.
The nearest floor, 45.7% below — buyers have tended to step in here.
The nearest ceiling, 3.9% above — a clean break opens room to run.
A major ceiling 37.0% above — clearing it would confirm fresh momentum.
Key MGRX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of MGRX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.5006 | Buy | $0.4893 | Buy |
| MA 10 | $0.4984 | Buy | $0.4816 | Buy |
| MA 20 | $0.441 | Buy | $0.4559 | Buy |
| MA 50 | $0.4107 | Buy | $0.4252 | Buy |
| MA 100 | $0.3943 | Buy | $0.4798 | Buy |
| MA 200 | $0.7291 | Sell | $0.8084 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 57.73 | Neutral |
| Stoch RSI (14) | 60.49 | Neutral |
| CCI (20) | 104.36 | Buy |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | 0.00 | Buy |
| ROC (12) | 48.53 | Buy |
| Bollinger %B (20,2) | 0.85 | Neutral |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | 1.04 | Buy |
| Awesome (5,34) | 0.09 | Buy |
| Ultimate (7,14,28) | 57.09 | Neutral |
| Momentum (10) | 0.14 | Buy |
| Aroon Osc (25) | 4.00 | Buy |
| Hull MA (9) | 0.46 | Buy |
| ADX (14) | 19.23 | Neutral |
| ATR (14) | 0.06 | Info |
The 30‑day technical picture shows bullish sentiment overall. RSI14 is 60. The moving averages stand at SMA50 $0.4107 and SMA200 $0.7291. Near‑term support is identified at $0.291 and resistance at $0.557. The 30‑day price range runs from a low of $0.2797 to a high of $1.11, with an annualized volatility of 200%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.162 | $0.536 | $1.01 | 0% | Neutral | |
| $0.604 | $0.8289 | $1.23 | +55% | Bullish | |
| $0.6967 | $1.02 | $1.61 | +90% | Bullish | |
| $0.6891 | $1.06 | $1.76 | +98% | Bullish | |
| $0.595 | $0.9596 | $1.66 | +79% | Bullish | |
| $0.6153 | $1.04 | $1.86 | +94% | Bullish | |
| $0.644 | $1.13 | $2.09 | +111% | Bullish | |
| $0.8969 | $1.64 | $3.12 | +207% | Bullish | |
| $1.05 | $2.01 | $3.92 | +275% | Bullish | |
| $0.9445 | $1.87 | $3.73 | +249% | Bullish | |
| $1.31 | $2.91 | $6.38 | +443% | Bullish | |
| $2.30 | $5.11 | $11.76 | +854% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $0.162 | $0.536 | $0.7451 | +0.00% |
| September 2026 | $0.5144 | $0.6252 | $0.7929 | +16.65% |
| October 2026 | $0.5197 | $0.6406 | $0.8289 | +2.45% |
| November 2026 | $0.5701 | $0.7107 | $0.9346 | +10.94% |
| December 2026 | $0.6005 | $0.7566 | $1.01 | +6.46% |
Click any year to see its month-by-month MGRX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect MGRX to range from $0.162 to $1.01 through 2026. The $0.536 average target implies a 0% move from current prices. A consolidation phase looks the most probable path here.
The MGRX price prediction for 2027 points to an average of $0.8289 (low $0.604, high $1.23) — a potential gain of +55% on today's $0.536. Momentum favours further upside here.
In 2028, MGRX is projected to trade between $0.6967 and $1.61, averaging $1.02 — a potential gain of +90% from today's $0.536. That is up +23% on the projected 2027 average. Buyers look set to stay in control over this stretch.
Mangoceuticals, Inc.'s 2029 outlook centres on $1.06, within a $0.6891 to $1.76 range. That is up +4% on the projected 2028 average. That marks a +98% change versus current levels. Momentum favours further upside here.
By 2030, MGRX could reach as high as $1.66, with a base case around $0.9596 and support toward $0.595 — roughly +79% from $0.536. Buyers look set to stay in control over this stretch.
Expect MGRX to range from $0.6153 to $1.86 through 2031. The $1.04 average target implies a +94% move from current prices. That is up +8% on the projected 2030 average. Momentum favours further upside here.
The MGRX price prediction for 2032 points to an average of $1.13 (low $0.644, high $2.09) — a potential gain of +111% on today's $0.536. Buyers look set to stay in control over this stretch.
In 2033, MGRX is projected to trade between $0.8969 and $3.12, averaging $1.64 — a potential gain of +207% from today's $0.536. That is up +45% on the projected 2032 average. Momentum favours further upside here.
Mangoceuticals, Inc.'s 2034 outlook centres on $2.01, within a $1.05 to $3.92 range. That is up +22% on the projected 2033 average. That marks a +275% change versus current levels. Buyers look set to stay in control over this stretch.
By 2035, MGRX could reach as high as $3.73, with a base case around $1.87 and support toward $0.9445 — roughly +249% from $0.536. Momentum favours further upside here.
Expect MGRX to range from $1.31 to $6.38 through 2040. The $2.91 average target implies a +443% move from current prices. That is up +56% on the projected 2035 average. Buyers look set to stay in control over this stretch.
The MGRX price prediction for 2050 points to an average of $5.11 (low $2.30, high $11.76) — a potential gain of +854% on today's $0.536. Momentum favours further upside here.
Investing $1,000 in MGRX today (≈ 1,865.671642 MGRX) could be worth
$9,535.92
+$8,535.92 (+854%) by 2050 · US Dollar
Based on the average projected MGRX price of $5.11 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in MGRXwould be worth at today's price.
$1,000 invested in MGRX on Jul 31, 2025 (≈ 595.238114 MGRX) would be worth
$319.05
-$680.95 (-68.1%) today · 0.32× · US Dollar
Based on a MGRX entry price of $1.68 vs. today's $0.536.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.521 | $1,028.79 | +2.9% |
| 1 month ago | $0.426 | $1,258.22 | +25.8% |
| 3 months ago | $0.318 | $1,685.53 | +68.6% |
| 6 months ago | $0.429 | $1,249.42 | +24.9% |
| 1 year ago | $1.68 | $319.05 | -68.1% |
| All time (3.4y) ago | $60 | $8.93 | -99.1% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our MGRX forecast.
Our base-case forecast reaches $1.10 around 2032.
Implied market cap at $1.10: $18.88M
The multi‑year forecast depicts a bullish trajectory with rising averages from 2026 through 2050. The 2026 avg is $0.5571 and the 2027 avg is $0.8593, then $1.06 in 2028 and $1.10 in 2029, followed by $0.9922 in 2030, $1.08 in 2031, $1.17 in 2032, $1.70 in 2033, and $2.08 in 2034, with $1.93 in 2035. The outlook continues to expand to $3.02 in 2040 and $5.27 in 2050, with max values reaching as high as $12.12 in 2050 and ROI up to 845.5%.
The sentiment is bullish across the longer horizon, though 2026 is labeled neutral. These are estimates, not guarantees, and depend on future market conditions and other factors.
Tap a question to reveal the answer.
The 2030 forecast lists min $0.6151, avg $0.9922, max $1.72 with ROI 78.1 and sentiment bullish.
The near‑term forecast for 2026 shows neutral sentiment with avg $0.5571 and ROI 0, while 2027 onward displays bullish sentiment with growing averages (e.g., 2027 avg $0.8593, 2028 avg $1.06, 2029 avg $1.10) and positive ROIs (54.3% in 2027, 89.8% in 2028, 97.3% in 2029). The long‑term view projects substantial upside to 2050 (avg $5.27, ROI 845.5%), but these are estimates only and not guarantees.
Yes. The 2034 forecast lists min $1.09, avg $2.08, max $4.06, implying a path that crosses the $2 level within that year.
Current price is $0.5571 and market cap is $9.56M.
The 30‑day range is $0.2797 to $1.11 with RSI14 at 60, SMA50 at $0.4107, SMA200 at $0.7291, and annualized volatility of 200%.
Mangoceuticals, Inc. Community Discussion
0Share your Mangoceuticals, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.